Eledon Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Liabilities
Eledon Pharmaceuticals, Inc. (ELDN) reported Increase (Decrease) in Other Operating Liabilities of -$36.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2017-05-03
- Eledon Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2017-03-31 was -$36.00K, a 194.74% decline year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2016-12-31 was -$36.00K, a 197.30% decline year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2016-09-30 was -$36.00K, a 194.74% decline year-over-year.
- Eledon Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for the quarter ending 2016-06-30 was $30.00K.
- Eledon Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for fiscal 2016 was -$4.00K, a 104.55% decline from fiscal 2015.
- Eledon Pharmaceuticals, Inc. increase (decrease) in other operating liabilities for fiscal 2015 was $88.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$36.00K 10-Q · filed 2017-05-03 | -$72.00K derived: sum of 2 quarters · filed 2017-05-03 | -$108.00K derived: sum of 3 quarters · filed 2017-05-03 | -$78.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$72.00K derived: sum of 2 quarters · filed 2017-03-03 | -$42.00K derived: sum of 3 quarters · filed 2017-03-03 | -$4.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$6.00K derived: sum of 2 quarters · filed 2016-11-03 | $32.00K 10-Q · filed 2016-11-03 | $69.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $68.00K 10-Q · filed 2016-08-04 | $105.00K derived: sum of 3 quarters · filed 2017-05-03 | $143.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | $38.00K 10-Q · filed 2017-05-03 | $75.00K derived: sum of 2 quarters · filed 2017-05-03 | $113.00K derived: sum of 3 quarters · filed 2017-05-03 | |
| 2015-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $75.00K derived: sum of 2 quarters · filed 2017-03-03 | $88.00K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $51.00K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $13.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |